Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.75 USD
−18.52 M USD
614.38 M USD
18.60 M
About ANI Pharmaceuticals, Inc.
Sector
Industry
CEO
Nikhil Lalwani
Website
Headquarters
Baudette
Founded
1996
ISIN
US00182C1036
FIGI
BBG000KK1L04
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange ANI Pharmaceuticals, Inc. stocks are traded under the ticker ANIP.
We've gathered analysts' opinions on ANI Pharmaceuticals, Inc. future price: according to them, ANIP price has a max estimate of 120.00 USD and a min estimate of 77.00 USD. Watch ANIP chart and read a more detailed ANI Pharmaceuticals, Inc. stock forecast: see what analysts think of ANI Pharmaceuticals, Inc. and suggest that you do with its stocks.
ANIP reached its all-time high on Aug 1, 2024 with the price of 64.99 USD, and its all-time low was 38.68 USD and was reached on Apr 24, 2023. View more price dynamics on ANIP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track ANI Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ANI Pharmaceuticals, Inc. is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
ANIP earnings for the last quarter are 1.80 USD per share, whereas the estimation was 1.41 USD resulting in a 28.05% surprise. The estimated earnings for the next quarter are 1.67 USD per share. See more details about ANI Pharmaceuticals, Inc. earnings.
ANI Pharmaceuticals, Inc. revenue for the last quarter amounts to 211.37 M USD, despite the estimated figure of 190.12 M USD. In the next quarter, revenue is expected to reach 206.05 M USD.
ANIP net income for the last quarter is 7.73 M USD, while the quarter before that showed 14.12 M USD of net income which accounts for −45.24% change. Track more ANI Pharmaceuticals, Inc. financial stats to get the full picture.
No, ANIP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 5, 2025, the company has 897 employees. See our rating of the largest employees — is ANI Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANI Pharmaceuticals, Inc. EBITDA is 95.43 M USD, and current EBITDA margin is 11.39%. See more stats in ANI Pharmaceuticals, Inc. financial statements.
Like other stocks, ANIP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANI Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.